Lilith Games helped artificial intelligence software developer Inspir.ai secure $46.3m while Microsoft AI spinoff Xiaoice closed its series A round at a billion-dollar valuation.

Q&A with Gayathri “G” Radhakrishnan, director of venture capital, Micron AI Fund

Th heart disease treatment developer has secured $248m in funding since being formed to exploit UT Southwestern and Gladstone Institute research.

Alphabet, GeneScience, AstraZeneca, Shire, Novartis, Ping An, KPC and Stevanato are in line for exits after the drug delivery technology developer filed to go public.

The Boston Scientific-backed medical device maker has filed to raise up to $100m in an offering on the Nasdaq Global Market.

The GV-backed heart disease treatment developer intends to go public this year having secured $248m in venture funding.

Microsoft is reportedly paying over $500m for the MassMutual Ventures and National Grid Partners-backed cybersecurity software provider.

Daryush Ila, a 10-year tech transfer veteran at FSU, will assume the vice-president for innovation and research role at UWG.

Dell-backed cybersecurity software producer Netskope has raised just over $1bn to date, having completed a $300m round led by Iconiq Growth.

Bow Capital has helped supply fresh funding for the equity-free capital provider to boost its expansion and broaden its product offering.